JP2021506815A5 - - Google Patents

Download PDF

Info

Publication number
JP2021506815A5
JP2021506815A5 JP2020532820A JP2020532820A JP2021506815A5 JP 2021506815 A5 JP2021506815 A5 JP 2021506815A5 JP 2020532820 A JP2020532820 A JP 2020532820A JP 2020532820 A JP2020532820 A JP 2020532820A JP 2021506815 A5 JP2021506815 A5 JP 2021506815A5
Authority
JP
Japan
Prior art keywords
item
peptide
composition
items
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020532820A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021506815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/001511 external-priority patent/WO2019116092A1/en
Publication of JP2021506815A publication Critical patent/JP2021506815A/ja
Publication of JP2021506815A5 publication Critical patent/JP2021506815A5/ja
Priority to JP2023062404A priority Critical patent/JP7760174B2/ja
Priority to JP2024204161A priority patent/JP2025028940A/ja
Pending legal-status Critical Current

Links

JP2020532820A 2017-12-15 2018-11-30 界面活性ペプチドナノ構造および薬物送達における使用 Pending JP2021506815A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023062404A JP7760174B2 (ja) 2017-12-15 2023-04-06 界面活性ペプチドナノ構造および薬物送達における使用
JP2024204161A JP2025028940A (ja) 2017-12-15 2024-11-22 界面活性ペプチドナノ構造および薬物送達における使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762599566P 2017-12-15 2017-12-15
US62/599,566 2017-12-15
PCT/IB2018/001511 WO2019116092A1 (en) 2017-12-15 2018-11-30 Surfactant peptide nanostructures and uses in drug delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023062404A Division JP7760174B2 (ja) 2017-12-15 2023-04-06 界面活性ペプチドナノ構造および薬物送達における使用

Publications (2)

Publication Number Publication Date
JP2021506815A JP2021506815A (ja) 2021-02-22
JP2021506815A5 true JP2021506815A5 (https=) 2022-01-06

Family

ID=65276214

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020532820A Pending JP2021506815A (ja) 2017-12-15 2018-11-30 界面活性ペプチドナノ構造および薬物送達における使用
JP2023062404A Active JP7760174B2 (ja) 2017-12-15 2023-04-06 界面活性ペプチドナノ構造および薬物送達における使用
JP2024204161A Pending JP2025028940A (ja) 2017-12-15 2024-11-22 界面活性ペプチドナノ構造および薬物送達における使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023062404A Active JP7760174B2 (ja) 2017-12-15 2023-04-06 界面活性ペプチドナノ構造および薬物送達における使用
JP2024204161A Pending JP2025028940A (ja) 2017-12-15 2024-11-22 界面活性ペプチドナノ構造および薬物送達における使用

Country Status (6)

Country Link
US (2) US11324703B2 (https=)
EP (1) EP3723726A1 (https=)
JP (3) JP2021506815A (https=)
CN (2) CN117085140A (https=)
IL (1) IL275380A (https=)
WO (1) WO2019116092A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021506815A (ja) 2017-12-15 2021-02-22 株式会社スリー・ディー・マトリックス 界面活性ペプチドナノ構造および薬物送達における使用
EP3754336B1 (en) * 2018-02-15 2024-01-17 3-D Matrix, Ltd. Cancer lesion tissue evaluation for optimizing effect of boron neutron capture therapy
US20250059231A1 (en) * 2021-09-30 2025-02-20 Protinhi B.V. Protease inhibitors

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4466641A (en) 1982-08-04 1984-08-21 The Lockformer Company Duct connecting system
US4642117A (en) 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
US5236903A (en) 1988-06-24 1993-08-17 Ichiro Azuma Polypeptide comprising repeated cell-adhesive core sequences
US5110604A (en) 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
US5126141A (en) 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5629291A (en) 1992-01-31 1997-05-13 La Jolla Cancer Research Foundation Methods of modulating fibronectin extracellular matrix assembly
US5292514A (en) 1992-06-24 1994-03-08 Minnesota Mining And Manufacturing Company Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5955343A (en) 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
GB2274988A (en) 1993-02-10 1994-08-17 Mcconn Stern Rita Iodine containing wound-healing preparations
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5773577A (en) 1994-03-03 1998-06-30 Protein Polymer Technologies Products comprising substrates capable of enzymatic cross-linking
US5527610A (en) 1994-05-20 1996-06-18 The Uab Research Foundation Elastomeric polypeptide matrices for preventing adhesion of biological materials
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
EP0874910A4 (en) 1995-06-07 1999-04-21 Life Technologies Inc ENHANCED CATIONIC LIPID TRANSFECTION BY PEPTIDES
WO1996040033A1 (en) 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
CZ318998A3 (cs) 1996-04-04 1999-09-15 Baxter Aktiengesellschaft Hemostatická houba na bázi kolagenu, způsob její přípravy, kryt na ránu a kit k přípravě tohoto krytu
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
US6083522A (en) 1997-01-09 2000-07-04 Neucoll, Inc. Devices for tissue repair and methods for preparation and use thereof
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US6428811B1 (en) 1998-03-11 2002-08-06 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
US6046160A (en) 1999-07-22 2000-04-04 Deroyal Industries, Inc. Composition and method for enhancing wound healing
ATE389416T1 (de) 2000-05-16 2008-04-15 Genentech Inc Behandlung von knorpelerkrankungen
US20020132274A1 (en) 2001-01-17 2002-09-19 Nevalainen Marja T. Diagnostic and monitorings methods for cancer
JP4104462B2 (ja) 2001-01-25 2008-06-18 ニコメド ファーマ エイエス コラーゲンスポンジを調製する方法、コラーゲンフォームの一部を抽出するための装置、および伸長したコラーゲンスポンジ
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
DE60230593D1 (de) 2001-02-06 2009-02-12 Massachusetts Inst Technology Peptidgerüstverkapselung von gewebszellen und verwendungen davon
US7179784B2 (en) 2001-07-10 2007-02-20 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
AU2003222167A1 (en) 2002-04-02 2003-10-20 Northwestern University Peptide amphiphile solutions and self assembled peptide nanofiber networks
WO2003095972A2 (en) 2002-05-09 2003-11-20 The Regents Of The University Of California Method of analyzing ataxia-telangiectasia protein
AU2003249606A1 (en) 2002-05-13 2003-12-02 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
EP1542709A2 (en) 2002-08-06 2005-06-22 EPIX Pharmaceuticals, Inc. Peptide aggregates
US7713923B2 (en) 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
EP2711025A3 (en) 2003-06-25 2014-09-10 Massachusetts Institute of Technology Self-assembling peptides incorporating modifications and methods of use thereof
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
JP5255274B2 (ja) 2004-07-06 2013-08-07 スリーディー マトリックス, インコーポレイテッド 精製両親媒性ペプチド組成物およびその使用
JP2008526749A (ja) 2005-01-04 2008-07-24 ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド 自己アセンブリするペプチドナノファイバーを用いたpdgfの徐放性の送達
DK1879606T3 (da) 2005-04-25 2013-09-23 Massachusetts Inst Technology Selvorganiserende peptider til fremme af hæmostase
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
JP4982841B2 (ja) 2005-10-12 2012-07-25 国立大学法人名古屋大学 再生医療骨組成物
US8796544B2 (en) 2005-12-14 2014-08-05 Massachusetts Institute Of Technology Bio-sensitized solar cells (BSSC)
ES2673947T3 (es) 2006-04-25 2018-06-26 Massachusetts Institute Of Technology Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas
WO2008039483A2 (en) 2006-09-26 2008-04-03 Massachusetts Institute Of Technology Modified self-assembling peptides
WO2008073392A2 (en) 2006-12-11 2008-06-19 3D Matrix, Inc. Compositions and methods for cardiac tissue protection and regeneration
US9415084B2 (en) 2007-03-14 2016-08-16 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
US20090069547A1 (en) * 2007-05-01 2009-03-12 Massachusetts Institute Of Technology Stabilization of mammalian membrane proteins by short surfactant peptides
WO2008136820A1 (en) 2007-05-01 2008-11-13 Massachusetts Institute Of Technology Stabilization of mammalian membrane proteins by short surfactant peptides
US9714941B2 (en) 2007-07-31 2017-07-25 Massachusetts Institute Of Technology Bio-sensing nanodevice
WO2010014903A1 (en) 2008-07-31 2010-02-04 Massachusetts Institute Of Technology Multiplexed olfactory receptor-based microsurface plasmon polariton detector
US9133484B2 (en) 2008-08-27 2015-09-15 3-D Matrix, Ltd. Transfection agent
RU2011118341A (ru) 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
CN101514225B (zh) 2008-10-13 2011-09-14 西安蓝晶生物科技有限公司 自聚体多肽及其制备方法和应用
JP2010222338A (ja) * 2009-02-27 2010-10-07 Three D Matrix:Kk 核酸移送担体
CN105664223B (zh) * 2009-10-26 2018-12-04 日产化学工业株式会社 化妆料、皮肤外用剂、以及医疗用仪器
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
JP2011126855A (ja) 2009-12-15 2011-06-30 Three D Matrix:Kk タンパク質の凝集抑制剤
US20130236891A1 (en) 2010-08-20 2013-09-12 3-D Matrix, Ltd. Method and composition for the treatment, prevention, and diagnosis of cancer containing or derived from cancer stem cells
US9149511B2 (en) 2011-06-30 2015-10-06 Ethicon, Inc. Procoagulant peptides and their derivatives and uses therefor
WO2013181511A1 (en) * 2012-05-31 2013-12-05 Massachusetts Institute Of Technology Sustained delivery of molecules using peptide surfactants and uses thereof
GB2503701B (en) 2012-07-04 2015-08-26 Shameem Anthony Carl Sampath Limb exercise device
WO2014008400A2 (en) 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
US9140677B2 (en) 2012-08-13 2015-09-22 Massachusetts Institute Of Technology Methods and apparatus for artificial olfaction
SG11201506232VA (en) 2013-03-06 2015-09-29 3D Matrix Ltd Surgical methods employing purified amphiphilic peptide compositions
ES2756531T3 (es) 2013-08-22 2020-04-27 Arch Biosurgery Inc Mallas implantables para controlar el movimiento de fluidos
RU2016139369A (ru) 2014-03-10 2018-04-10 3-Д Матрикс, Лтд. Композиции самоорганизующихся пептидов
JP6554121B2 (ja) 2014-03-10 2019-07-31 株式会社スリー・ディー・マトリックス 気管支閉鎖剤としての自己組織化ペプチド
EP3116522B1 (en) 2014-03-10 2019-05-08 3-D Matrix Ltd. Autoassembling peptides for the treatment of pulmonary leakage
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
BR112016019510A2 (pt) 2014-03-10 2017-10-24 3 D Matrix Ltd esterilização e filtração de composições de peptídeos
PL229030B1 (pl) 2014-03-13 2018-05-30 Zygmunt Jerzy Szymański Nanopreparat bakteriobójczy
JP2014208669A (ja) 2014-06-17 2014-11-06 株式会社スリー・ディー・マトリックス タンパク質の凝集抑制剤
JP2016028102A (ja) 2015-10-21 2016-02-25 株式会社スリー・ディー・マトリックス タンパク質の凝集抑制剤
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
WO2017164334A1 (ja) 2016-03-23 2017-09-28 公益財団法人 川崎市産業振興財団 ホウ素クラスター結合ペプチド化合物
WO2018097335A1 (ja) 2016-11-25 2018-05-31 国立大学法人 岡山大学 ホウ素中性子捕捉療法のための新規bsh複合体
WO2019093308A1 (ja) 2017-11-09 2019-05-16 国立大学法人広島大学 miRNAを含むがん治療用医薬組成物
JP2021506815A (ja) 2017-12-15 2021-02-22 株式会社スリー・ディー・マトリックス 界面活性ペプチドナノ構造および薬物送達における使用

Similar Documents

Publication Publication Date Title
JP7796636B2 (ja) ヒトトランスフェリンレセプター結合ペプチド
EP2900255B1 (en) Insulin analog dimers
JP2011511753A5 (https=)
RU2008141280A (ru) Агонисты рецептора нейромедина u и их применение
JP2015532283A5 (https=)
JPH0532696A (ja) 副甲状腺ホルモン誘導体
RU2016120641A (ru) Новые полипептиды
JP2013531660A5 (https=)
JP2021506815A5 (https=)
JP2004537581A5 (https=)
JP2004535461A5 (https=)
US10632187B2 (en) Hemagglutinin-binding peptide
US9334314B2 (en) Peptide compounds derived from melanotransferrin and uses thereof
CN105837675A (zh) 一组阳离子抗菌肽及其制备方法
EP4389758A1 (en) Human transferrin receptor?binding peptide
JP2024504136A5 (https=)
CN114341156A (zh) 包封有肽的铁蛋白
US20060275213A1 (en) Tumor targeting agents and uses thereof
JP2967956B2 (ja) ペプチドまたはその塩
Futaki Design and Creation of Functional Membrane-Interacting Peptides
CN100365014C (zh) 肿瘤靶向剂及其应用
US3639383A (en) Complexes of a.c.t.h. peptides and polyphosphoric acids
CN111164094B (zh) 抗癌肽及其用途
EP4667483A1 (en) Human transferrin receptor-binding peptide
WO2016033602A1 (en) Activation of adaptive immune processes for the treatment of cancers and infectious diseases